Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MYELOGENOUS LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 5294 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Bruserud, O
      Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia

      INTERNATIONAL IMMUNOPHARMACOLOGY
    3. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    4. Syme, RM; Bryan, TL; Gluck, S
      Dendritic cell-based therapy: A review focusing on antigenic selection

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Hui, N; Le Marer, N
      alpha-2,6-sialylation regulation in CD34(+) progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    6. Chiorean, EG; Miller, JS
      The biology of natural killer cells and implications for therapy of human disease

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    7. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    8. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    9. Maki, G
      Ex vivo purging of stem cell autografts using cytotoxic cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    10. Godder, KT; Henslee-Downey, PJ
      Colony-stimulating factors in stem cell transplantation: Effect on qualityof life

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    11. Uyl-de Groot, CA; Hartog, JGD; Huijgens, PC; Willemze, R; Van Ineveld, BM
      Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Meijerink, J; Mandigers, C; van de Locht, L; Tonnissen, E; Goodsaid, F; Raemaekers, J
      A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR

      JOURNAL OF MOLECULAR DIAGNOSTICS
    13. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    14. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    15. Sykes, M
      Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: Isthere a solid approach?

      JOURNAL OF IMMUNOTHERAPY
    16. Grimwade, D
      The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    17. Chase, A; Huntly, BJP; Cross, NCP
      Cytogenetics of chronic myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    18. Hall, GW
      Childhood myeloid leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    19. Kearney, L
      Molecular cytogenetics

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    20. Mrozek, K; Heinonen, K; Bloomfield, CD
      Clinical importance of cytogenetics in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    21. Dash, A; Gilliland, DG
      Molecular genetics of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    22. Lowenberg, B
      Prognostic factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    23. Langmuir, PB; Aplenc, R; Lange, BJ
      Acute myeloid leukaemia in children

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    24. Burnett, AK
      Treatment of acute myeloid leukaemia in younger patients

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    25. Dann, EJ; Rowe, JM
      Biology and therapy of secondary leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    26. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    27. Estey, EH
      Growth factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    28. Sonneveld, P; List, AF
      Chemotherapy resistance in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    29. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    30. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    31. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    32. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    33. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    34. Stark, G; O'Brien, SG
      An update on chronic myeloid leukaemia

      CLINICAL MEDICINE
    35. Moritz, T; Williams, DA
      Marrow protection - transduction of hematopoietic cells with drug resistance genes

      CYTOTHERAPY
    36. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY

    37. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation

      CYTOTHERAPY
    38. Szer, J; Lieschke, GJ
      Small molecule: large hopes

      INTERNAL MEDICINE JOURNAL
    39. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
      Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

      INTERNAL MEDICINE JOURNAL
    40. Schanz, U
      Allogeneic haematopoietic stem cell transplantation with reduced intensityconditioning regimens ("minitransplants")

      SWISS MEDICAL WEEKLY
    41. Timmermann, S; Lehrmann, H; Polesskaya, A; Harel-Bellan, A
      Histone acetylation and disease

      CELLULAR AND MOLECULAR LIFE SCIENCES
    42. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    43. Krystal, GW
      Mechanisms of resistance to imatinib (ST1571) and prospects for combination with conventional, chemotherapeutic agents

      DRUG RESISTANCE UPDATES
    44. Weisberg, E; Griffin, JD
      Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients

      DRUG RESISTANCE UPDATES
    45. Snider, JV; Wechser, MA; Lossos, IS
      Human disease characterization: real-time quantitative PCR analysis of gene expression

      DRUG DISCOVERY TODAY
    46. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    47. Sangfelt, O; Strander, H
      Apoptosis and cell growth inhibition as antitumor effector functions of interferons

      MEDICAL ONCOLOGY
    48. Russell, AI; Lawson, WA; Haskard, DO
      Potential new therapeutic options in Behcet's syndrome

      BIODRUGS
    49. Frankel, AE; Schuster, MW; Jurcic, JG
      Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

      BIODRUGS
    50. Deruelle, R; Catteau, B; Segard, M; De Lassalle, EM; Fenaux, P; Piette, F
      Cutaneous granulocytic sarcoma arising at the site of radiotherapy for breast carcinoma

      EUROPEAN JOURNAL OF DERMATOLOGY
    51. Bruserud, O; Foss, B; Petersen, H
      Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)

      EUROPEAN CYTOKINE NETWORK
    52. Hansen, CM; Binderup, L; Hamberg, KJ; Carlberg, C
      Vitamin D and cancer: Effects of 1,25(OH)(2)D-3 and its analogs on growth control and tumorigenesis

      FRONTIERS IN BIOSCIENCE
    53. Thomas, JG; Olson, JM; Tapscott, SJ; Zhao, LP
      An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles

      GENOME RESEARCH
    54. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    55. Bagg, A
      Minimal residual disease: How low do we go?

      MOLECULAR DIAGNOSIS
    56. Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D
      Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    57. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    58. Friedberg, JW; Neuberg, D; Monson, J; Jallow, H; Nadler, LM; Freedman, AS
      The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    59. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    60. Cao, TM; Horning, SF; Negrin, RS; Hu, WW; Johnston, LF; Taylor, TL; Shizuru, JA; Hoppe, RT; Brown, BW; Blume, KG; Stockerl-Goldstein, K
      High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    61. Patterson, AE; Korngold, R
      Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    62. Ho, VT; Weller, E; Lee, SJ; Alyea, EP; Antin, JH; Soiffer, RJ
      Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    63. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    64. Verneris, MR; Ito, M; Baker, E; Arshi, A; Negrin, RS; Shizuru, JA
      Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    65. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    66. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    67. Weissman, IL; Anderson, DJ; Gage, F
      Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations

      ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY
    68. Hartwig, UF; Keller, U; Huber, C; Peschel, C
      Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1 beta antisense RNA

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    69. Efferth, T; Futscher, BW; Osieka, R
      5-azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs

      BLOOD CELLS MOLECULES AND DISEASES
    70. Lichtman, MA
      Differentiation versus maturation of neoplastic hematopoietic cells: An important distinction

      BLOOD CELLS MOLECULES AND DISEASES
    71. Van Etten, RA
      Retroviral transduction models of Ph+ leukemia: Advantages and limitationsfor modeling human hematological malignancies in mice

      BLOOD CELLS MOLECULES AND DISEASES
    72. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    73. Pabst, T; Mueller, BU; Harakawa, N; Schoch, C; Haferlach, T; Behre, G; Hiddemann, W; Zhang, DE; Tenen, DG
      AML1-ETO downregulates the granulocytic differentiation factor C/EBP alphain t(8;21) myeloid leukemia

      NATURE MEDICINE
    74. Ratain, MJ; Relling, MV
      Gazing into a crystal ball-cancer therapy in the post-genomic era

      NATURE MEDICINE
    75. Bornhauser, M; Thiede, C; Platzbecker, U; Jenke, A; Helwig, A; Plettig, R; Freiberg-Richter, J; Rollig, C; Geissler, G; Lutterbeck, K; Oelschlagel, U; Ehninger, G
      Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients

      CLINICAL CANCER RESEARCH
    76. Gore, SD; Weng, LJ; Zhai, S; Figg, WD; Donehower, RC; Dover, GJ; Grever, M; Griffin, CA; Grochow, LB; Rowinsky, EK; Zabalena, Y; Hawkins, EK; Burks, K; Miller, CB
      Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    77. Narla, RK; Dong, YH; Klis, D; Uckun, FM
      Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity

      CLINICAL CANCER RESEARCH
    78. Nimmanapalli, R; Porosnicu, M; Nguyen, D; Worthington, E; O'Bryan, E; Perkins, C; Bhalla, K
      Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

      CLINICAL CANCER RESEARCH
    79. Mohr, M; Dalmis, F; Hilgenfeld, E; Oelmann, E; Zuhlsdorf, M; Kratz-Albers, K; Nolte, A; Schmitmann, C; Onaldi-Mohr, D; Cassens, U; Serve, H; Sibrowski, W; Kienast, J; Berdel, WE
      Simultaneous immunomagnetic CD34+cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma

      CLINICAL CANCER RESEARCH
    80. Banerjee, A; Shannon, KM
      Leukemic transformation in patients with severe congenital neutropenia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    81. Taub, JW
      Relationship of chromosome 21 and acute leukemia in children with Down syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    82. Shearer, P; Kapoor, G; Beckwith, JB; Takashima, J; Breslow, N; Green, DM
      Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    83. Monteleone, PM; Steele, DA; King, AK; Konefal, S; Kelleher, JF
      Bilateral breast relapse in acute myelogenous leukemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    84. McDermott, MB; Corbally, MT; O'Marcaigh, AS
      Extracutaneous Sweet syndrome involving the gastrointestinal tract in a patient with Fanconi anemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    85. Karlic, H; Louda, N; Pfeilstocker, M; Keil, F; Lohninger, A; Pittermann, E; Paukovits, J
      Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1 alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)

      STEM CELLS
    86. Cutler, C; Antin, JH
      Peripheral blood stem cells for allogeneic transplantation: A review

      STEM CELLS
    87. Bruserud, O; Gjertsen, BT; Foss, B; Huang, TS
      New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches

      STEM CELLS
    88. Anasetti, C; Petersdorf, EW; Martin, PJ; Woolfrey, A; Hansen, JA
      Trends in transplantation of hematopoietic stem cells from unrelated donors

      CURRENT OPINION IN HEMATOLOGY
    89. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    90. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    91. Balducci, L; Hardy, CL; Lyman, GH
      Hematopoietic growth factors in the older cancer patient

      CURRENT OPINION IN HEMATOLOGY
    92. Holdsworth, MT; Mathew, P
      Efficacy of colony-stimulating factors in acute leukemia

      ANNALS OF PHARMACOTHERAPY
    93. Gaur, AH; Patrick, CC; McCullers, JA; Flynn, PM; Pearson, TA; Razzouk, BI; Thompson, SJ; Shenep, JL
      Bacillus cereus bacteremia and meningitis in immunocompromised children

      CLINICAL INFECTIOUS DISEASES
    94. Fioretos, T; Panagopoulos, I; Lassen, C; Swedin, A; Billstrom, R; Isaksson, M; Strombeck, B; Olofsson, T; Mitelman, F; Johansson, B
      Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

      GENES CHROMOSOMES & CANCER
    95. Jeffs, AR; Wells, E; Morris, CM
      Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions

      GENES CHROMOSOMES & CANCER
    96. Sohal, J; Chase, A; Mould, S; Corcoran, M; Oscier, D; Iqbal, S; Parker, S; Welborn, J; Harris, RI; Martinelli, G; Montefusco, V; Sinclair, P; Wilkins, BS; van den Berg, H; Vanstraelen, D; Goldman, JM; Cross, NCP
      Identification of four new translocations involving FGFRI in myeloid disorders

      GENES CHROMOSOMES & CANCER
    97. Jamal, R; Taketani, T; Taki, T; Bessho, F; Hongo, T; Hamaguchi, H; Horiike, S; Taniwaki, M; Hanada, R; Nakamura, H; Hayashi, Y
      Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia

      GENES CHROMOSOMES & CANCER
    98. Metzke-Heidemann, S; Harder, L; Gesk, S; Schoch, R; Jenisch, S; Grote, W; Siebert, R; Schlegelberger, B
      Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia

      GENES CHROMOSOMES & CANCER
    99. Andersen, MK; Christiansen, DH; Kirchhoff, M; Pedersen-Bjergaard, J
      Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents

      GENES CHROMOSOMES & CANCER
    100. Rudin, CM; Thompson, CB
      Transcriptional activation of short interspersed elements by DNA-damaging agents

      GENES CHROMOSOMES & CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 02:54:15